HIM
BMY icon

Hutchens Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Hutchens Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45,385
Closed -$2.45M – 53
2016
Q3 		$2.45M Buy
45,385
+16,575
+58% +$1.06M 2.3% 13
2016
Q2 		$2.12M Buy
+28,810
New +$2.04M 2.03% 23

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Hutchens Investment Management's BMY Position: Q4 2016 in Review

Hutchens Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 45,385 shares — an estimated $2.45M sold.

Hutchens Investment Management first reported a position in BMY in Q2 2016 and held it in 2 quarters. The position peaked at $2.45M in Q3 2016. 1,602 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Hutchens Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
  • Hutchens Investment Management sold 45,385 Bristol-Myers Squibb shares in Q4 2016, an estimated $2.45M.
  • Hutchens Investment Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 2 quarters.
  • Hutchens Investment Management's Bristol-Myers Squibb position peaked at $2.45M in Q3 2016.
  • 1,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Hutchens Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.